(Q38668602)

5 September 2017

1 reference

title

New therapeutic modalities in hypertension: focus on a new calcium antagonist-nicardipine (English)

1 reference

5 September 2017

Frishman WH

1

1 reference

5 September 2017

publication date

1 June 1989

1 reference

The Journal of Clinical Pharmacology

5 September 2017

published in

1 reference

5 September 2017

volume

29

1 reference

5 September 2017

issue

6

1 reference

5 September 2017

page(s)

481-487

1 reference

'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Cardiovascular pharmacology of nicardipine in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Coronary and systemic hemodynamic effects of nicardipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Nicardipine hydrochloride in essential hypertension--a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Anti-hypertensive dose-response effects of nicardipine in stable essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Effect of nicardipine in elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Blood pressure, heart rate and A-V conduction responses to nicardipine in hypertensive patients receiving atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Comparison of the efficacy of nicardipine, a new calcium channel blocker, with nifedipine in the treatment of mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

Multiple oral doses of nicardipine, a calcium-entry blocker: effects on renal function, plasma renin activity, and aldosterone concentration in mild-to-moderate essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03368.X

10.1002/J.1552-4604.1989.TB03368.X

21 January 2018

Identifiers

DOI

1 reference

release_quhsg55mjrdj7cvqtpb3r5r7au

5 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/quhsg55mjrdj7cvqtpb3r5r7au

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference